Seattle-based biotech startup Parse Biosciences acquired Biomage, a software development company that analyzes data of single-cell RNA. The deal will support Parse Biosciences’ research of single cell analysis.
While details of the deal were not publicized, Biomage’s CEO now serves as Parse Biosciences’ head of bioinformatics. In addition, 10 Biomage employees will assume new roles at Parse Biosciences.
The deal follows a recent $50 million capital infusion received by Parse Biosciences in December.
“As more researchers continue to adopt single cell sequencing and expand the size of their projects, analysis can often become one of the bottlenecks,” said Alex Rosenberg, CEO of Parse Biologics. “Adding Biomage’s capabilities and expertise in single cell analysis and cloud computing will help Parse simplify single cell analysis for researchers.”